• Informasi Investor
  • Susunan Pemegang Saham
  • Struktur SOHO Group
  • Dividen
  • Harga Saham

Informasi Investor

PT SOHO GLOBAL HEALTH TBK

Stock Code

SOHO (Listed on the Indonesia Stock Exchange)

Company ID Number

9120202591076

Business Type

Holding Company Activities & Other Management Consulting Activities

Website

www.sohoglobalhealth.com

Establishment Year

1956

Stock Listing Date

8 September 2020

Address

Jl. Rawa Sumur II Kav. BB No. 3, Kawasan Industri Pulogadung, Kelurahan Jatinegara, Kecamatan Cakung, Jakarta Timur, 13930

Authorized Capital

Rp 1.431.756.078.000,-

Paid Up Capital

nominal Rp 634.584.119.500,- consisting of 1.269.168.239 shares

Nominal Value

Rp 500,-

Fiscal Year

January 1st - December 31st

Contact

Corporate Secretary

Tel : 62-21-2985-88888

Fax : 62-21-2985-8800

E-mail : corporate.secretary@sohoglobalhealth.com

Susunan Pemegang Saham

*As of 14 January 2021

Struktur SOHO Group

PT SOHO Global Health, Tbk.

PT SOHO Global Investment

PT SOHO Industri Pharmasi

Natural products in prescription market

Ownership:

99,64%

SOHO Global Health

0,36%

SOHO Global Investment

PT Universal Health Network

Multilevel marketing/direct selling segment

Ownership:

99,975%

SOHO Global Health

0,025%

SOHO Global Investment

PT Parit Padang Global

The distribution arm of our business

Ownership:

99,9999%

SOHO Global Health

0,0001%

SOHO Global Investment

PT SOHO Global Medika

Medical device & medical equipment segment

Ownership:

99,8%

SOHO Global Health

0,2%

SOHO Global Investment

Dewan Komisaris

Eng Liang Tan

President Commisioner, SGH since 1997

Since taking over as President Commissioner in 1997, Eng Liang has grown SOHO Global Health’s turnover more than 20-fold. Eng Liang won the Entrepreneur of the Year Award (EOY) Award 2018 in the Lifetime Achievement Award category and EOY 2010 in the Health Product Innovation category organized by Ernst & Young.

Received Postgraduate Master Degree in Management from the University of Bradford, England and German degree as Diplom Physiker (equivalent to MSc) in Physics (specializing in Nuclear Physics) from the University of Bochum, Germany.

Harry Salam

Independent Commisioner

Past Experience includes working as Management Director of Johnson & Johnson for Singapore, Indonesia, Malaysia, and Philippines, Commercial Director at AstraZeneca Indonesia, and other companies such as Astra Pharmaceutical Co, PT. Kalbe Farma, PT. Philips Ralin Electronics, and PT. Sandoz Biochemie Farma Indonesia.

Economics Degree from University of Trisakti.

Andy Nugroho Purwohardono

Commissioner

Past Experience includes working as Director of PT. Softex Indonesia, Director of PT. MAP Active Adiperkasa Tbk, Director of PT. Matahari Department Store Tbk, President Director and Head of Investment Banking of PT. Morgan Stanley Asia Indonesia, and various positions in Intel Corp, PT. SG Securities, ABN Amro Bank, and PT. Danareksa Securities. He is also currently a Commissioner at PT. Siloam International Hospitals Tbk, Commissioner at PT. MAP Active Adiperkasa Tbk, Director at PT. Link Net Tbk, and Senior Managing Director at CVC Asia Pacific Limited.

Bachelor of Science from Oregon State University, Corvallis, Oregon, USA and Master of Business Administration from The University of Texas, San Antonio, Texas, USA.

Direksi

Rogelio Paulino Jr. Castillo La O

President Director

Past experience includes working as Regional Director of SE Asia at Smile Train, Regional Director for ASEAN and Greater China at Pfizer Consumer Healthcare, Regional Director at Pfizer Pharmaceuticals.

Master in Business Management from AIM Manila and BSc in Commerce.

Piero Brambati

Director

Past experience includes healthcare coverage for $2B long-short hedge fund, management consulting at The Boston Consulting Group, project management at GSK and Nestle.

MBA from London Business School and MSc in Mechanical Engineering.

Yuliana Tjhai

Director

Past experience includes working as a Partner at Bahar & Partners, a leading law firm based in Jakarta.

Law degree from University of Indonesia and Master Degree in International Commercial Law from University of Nottingham.

Henryk Klakurka

Director

Past experience includes working as Advisor to Mylan Vice-Chairman and CEO in Mylan Labs Inc, Chief Executive Officer of the Merck Generics Group, Regional Director of The Americas Merck Generics Group, President of Novex Pharma Inc. Apotex Inc Division, Director of Manufacturing & Logistics for Latin America, Vice President of Operations, and Vice President of the Canadian Pharmaceutical Distribution Network (CPDN), and also Vice President - Marketing then Vice President of Manufacturing at Plow Canada Inc.

Bachelor of Science degree at the University of Toronto, Astra AB Management Development Program at the IMD School Business, Lausanne Switzerland, and the Management Development Program at the University of Merck, Kellogg, Insead, Hong Kong University of Science and Technology.

Tan Ting Luen

Director

He has over 13 years of experience as an investment professional in South East Asia. Through his career, he has deployed over US$2bn of capital across multiple sectors in Healthcare, TMT, FMCG, and Consumer Retail. He is also actively involved in managing all aspect of portfolio related work including financial reporting, performance monitoring and financing. He is currently a Managing Director at CVC Asia Pacific Pte. Ltd., part of the Southeast Asia team based in Singapore. Prior to joining CVC, he was an investment professional at Navis Capital Partners in Malaysia and worked at Maxis Communication Berhad (top 3 telecommunication company listed in the Kuala Lumpur Stock Exchange) in Corporate Finance.

He holds a master’s degree in mechanical engineering with first class honors from Imperial College, London. He has also passed level II of the CFA Program.

Wonbae Lee

Director

Past Experience includes working in GE Healthcare (Tokyo, Japan) as GM of Asia-Pacific Life Sciences and GM Japan, in AstraZeneca as President, Head of Primary Care BU, and Strategic Planning Director, in McKinsey & Company as Consultant, and also in Hudson Advisors LLC and Hyundai International Merchant Bank. He is also currently a Principal at CVC Capital Partners, Singapore.

He holds a Business Administration from Korea University and Master of Business Administration from Harvard Business School.

Tim Eksekutif

  • Rogelio Paulino Jr. Castillo La O

    Chief Executive Officer

  • Piero Brambati

    Chief Financial Officer

  • Yuliana Tjhai

    Senior Executive Vice President Legal, Compliance, Internal Audit, Corporate Secretary & Human Resources

  • Kalista Utama

    Vice President Manufacturing

  • DR. Raphael Aswin

    Vice President Research & Development, Regulatory, and Medical Affairs

  • Catharina Siswanti Librawati

    Vice President Alliance

  • Edwin Vega Darma

    Vice President Distribution Sales & Marketing

  • Pandy Harianto

    Vice President Distribution Operation & Supply Chain Management

  • Sylvia Andriani Rizal

    Vice President Consumer Healthcare

  • Sugiharjo

    Vice President Medical Healthcare

Annual General Meeting of Shareholders

2021
2020
2019
3 Mei 2021

Surat Keterangan Notaris (Ringkasan Risalah Rapat)

View
3 Mei 2021

[TEMPLATE] Surat Kuasa Menghadiri Rapat Umum Pemegang Saham Tahunan 2021

Template Surat Kuasa
View
3 Mei 2021

Ringkasan Risalah Rapat Umum Pemegang Saham Tahunan 2021

View
3 Mei 2021

Rapat Umum Pemegang Saham Tahunan 2021

Pengumuman
View
3 Mei 2021

Rapat Umum Pemegang Saham Tahunan 2021

Pemanggilan
View
3 Mei 2021

[BAHAN] Rapat Umum Pemegang Saham Tahunan 2021

Laporan Keuangan, Laporan Tahunan & Laporan Komite Audit, Profil, Rekomendasi Komite Audit, LRPD
View
21 Juni 2019

Rapat Umum Pemegang Saham Tahunan 2020

Pengumuman, Undangan, Agenda, dan Tata Tertib
View
21 Juni 2019

Rapat Umum Pemegang Saham Tahunan 2019

Undangan, Agenda, Tata Tertib, dan Template Surat Kuasa
View

Extraordinary General Meeting of Shareholders

2020
2019

1st Extraordinary Meeting

3 Maret 2020

Rapat Umum Pemegang Saham Luar Biasa 2020

Undangan, Agenda, Tata Tertib, dan Template Surat Kuasa
View

2nd Extraordinary Meeting

19 Juni 2020

Rapat Umum Pemegang Saham Luar Biasa 2020

Pengumuman, Undangan, Agenda, Klarifikasi Agenda, dan Tata Tertib
View

1st Extraordinary Meeting

26 November 2019

Rapat Umum Pemegang Saham Luar Biasa

Pengumuman, Undangan, Agenda, Tata Tertib, dan Template Surat Kuasa
View

Dividen

2021
Dividend Dividend per Share Cum Dividend Payment Date
Interim Dividend FY 2021 197 13 August 2021 27 August 2021
2020
Dividend Dividend per Share Cum Dividend Payment Date
Final Dividend FY 2020 236 18 May 2021 20 May 2021

Harga Saham

This stock price are intended for informational purpose only and shall not be the basis for trading purposes. All information are provided by Trading View, a third-party partner. SOHO Global Health does not provide any information for this feature.

Informasi medis yang terdapat pada website ini hanya ditujukan untuk praktisi kesehatan di Indonesia.

Informasi pada website ini ditujukan untuk memberikan jawaban yang bersifat ilmiah, berdasarkan bukti ilmiah dan berimbang atas pertanyaan medis Anda.

Informasi ini tidak ditujukan sebagai saran medis. Perawatan pasien merupakan tanggung jawab praktisi kesehatan berdasarkan praktek perijinannya serta pengalaman dan informasi spesifik pasien.

Apakah Anda praktisi kesehatan di Indonesia?